MAT I Inhibitors

Chemical inhibitors of methionine adenosyltransferase I (MAT I) employ various mechanisms to disrupt the enzyme's catalytic activity. Cycloleucine acts by competing with the enzyme's natural substrate, S-adenosylmethionine (SAM), for binding to the active site, which leads to reduced enzymatic activity. Similarly, compounds like 5'-Methylthioadenosine, 5'-Deoxy-5'-(methylthio)adenosine, and 4'-Thioadenosine are structural analogs that mimic SAM, thereby occupying the active site of MAT I and preventing the methyl group transfer that is pivotal to the enzyme's function. Sinefungin, another analog, binds to the SAM binding site, blocking the enzyme's ability to process SAM. Decarboxylated S-adenosylmethionine also competes with SAM at the active site, inhibiting the transfer of methyl groups which is a key step in the function of MAT I.Furthermore, periodate-oxidized adenosine can inhibit MAT I by covalently modifying the sulfhydryl groups of the enzyme, leading to a disruption of its active site and a consequent loss of activity. Inhibition can also occur indirectly; for instance, ornithine can reduce the availability of methionine, the substrate for SAM production, by competing for its cellular uptake. Ethionine, a methionine analog, can be adenosylated by MAT I, but it leads to the production of a non-functional S-adenosyl derivative, effectively acting as a chain terminator. The compound 3-Deazaadenosine is also known to increase SAH concentration, which in turn inhibits MAT I by preventing the proper binding and processing of SAM. DL-Homocysteine thiolactone hydrochloride increases the concentration of homocysteine, which competes with methionine for adenylation by MAT I, thus functionally inhibiting the enzyme by limiting SAM production. Each of these chemicals can disrupt the normal catalytic cycle of MAT I, highlighting their role as inhibitors.